2-nonylfuran | 68532-53-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: 2-nonylfuran
• CAS: 68532-53-6
• 化学式: C₁₃H₂₂O
• 分子量: 194.317
• InChiKey: BIRIRZLNKYBSCQ-UHFFFAOYSA-N

物化性质

• 沸点：
  100-103 °C(Press: 3 Torr)
• 密度：
  0.926 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  14
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.69
• 拓扑面积：
  13.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-溴壬烷 、 2-nonylfuran 生成 2,5-di(nonyl)furan
  参考文献：
  名称：

  MCKEOWN, NEIL B.;CHAMBRIER, ISABELLE;COOK, MICHAEL J., J. CHEM. SOC. PT 1. PERKIN TRANS.,(1990) N, C. 1169-1177

  摘要：

  DOI：
• 作为产物：
  描述：

  正辛基镁溴盐 在 乙醇 、 氨 、 lithium 、 sodium hydride 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 反应 79.25h， 生成 2-nonylfuran
  参考文献：
  名称：

  Massy-Westropp, Ralph A.; Warren, Richard F.O., Australian Journal of Chemistry, 1984, vol. 37, # 6, p. 1303 - 1311

  摘要：

  DOI：

文献信息

• Production of Polyester Blend of Poly(3-hydroxybutyrate-<i>co</i>-4-hydroxybutyrate) and Poly(3-hydroxyalkanoate) with Saturated and Unsaturated Monomers from 4-Hydroxybutyric Acid by<i>Chromobacterium</i>sp.
  作者：Hiroshi Kimura、Masanobu Iwama、Shintaro Sasaki、Makoto Takeishi

  DOI：10.1246/cl.1999.737

  日期：1999.8

  Chromobacterium sp. isolated from a river soil produced a polyester blend of poly(3-hydroxybutyrate-co-4-hydroxybutyrate)(P(3HB-co-4HB)) and poly(3-hydroxyalkanoate) (P(3HA)) consisting of both saturated 3-hydroxyalkanoic acid(3HA) units of even carbon number from C4 to C14 and unsaturated 3HA units of carbon number C12 and C14, when 4-hydroxybutyric acid(4HBA) was fed as the sole carbon sources.

  从河流土壤中分离出的克罗诺细菌（ChromoBActerium sp.）在以4-羟基丁酸（4HBA）作为唯一碳源时，产生了一种聚酯混合物，该混合物由聚（3-羟基丁酸-co-4-羟基丁酸）(P(3HB-co-4HB))和聚（3-羟基烷酸酯）(P(3HA))组成，包含了具有偶数碳链的饱和3-羟基烷酸（3HA）单元（从C4到C14）以及含有C12和C14的非饱和3HA单元。
• Volatiles from the ascomycete <i>Daldinia cf. childiae</i> (Hypoxylaceae), originating from China
  作者：Lukas Lauterbach、Tao Wang、Marc Stadler、Jeroen S. Dickschat

  DOI：10.1039/c9md00083f

  日期：——

  analysed by GC-MS. A total number of 33 compounds from different classes were rigorously identified by comparison of mass spectra to library spectra and of retention indices to tabulated data from the literature. For unknown compounds structural suggestions were delineated from the mass spectra and verified by chemical synthesis of reference materials. Through this approach two 2-alkylated furan derivatives

  来自真菌Daldinia 的分离物的挥发物 cf. childiae是从中国采集的标本中获得的，使用闭环剥离装置收集并通过 GC-MS 进行分析。通过将质谱与库谱以及保留指数与文献中的表格数据进行比较，严格鉴定了来自不同类别的总共 33 种化合物。对于未知化合物，从质谱中描绘出结构建议，并通过参考材料的化学合成进行验证。通过这种方法，鉴定出了两种 2-烷基化呋喃衍生物，表明Daldinia属仍然是发现新型次生代谢物的有趣来源。进行了(1,2- 13 C 2 )乙酸钠喂养实验，以研究有利于非酶促环化步骤的聚酮化合物5-羟基-2-甲基-4-苯并二氢吡喃酮的生物合成。
• LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR USE IN THE TREATMENT OF ATROPHIC VAGINITIS
  申请人：Avoscience, LLC

  公开号：US20170312246A1

  公开（公告）日：2017-11-02

  Provided herein are lipidic furan, pyrrole, and thiophene compounds, compositions, and methods using such compounds and compositions for the treatment of atrophic vaginitis. Specifically, the invention includes administering an effective amount of a compound of Formula I, I′, or I″, or a pharmaceutically acceptable composition, salt, isotopic analog, prodrug, or combination thereof, to a subject suffering from atrophic vaginitis.

  本文提供了脂质类呋喃、吡咯和噻吩化合物、组合物以及使用这些化合物和组合物治疗萎缩性阴道炎的方法。具体而言，本发明包括向患有萎缩性阴道炎的受试者投与化合物I、I'或I"的有效量，或者药学上可接受的组合物、盐、同位素类似物、前药或其组合物。
• Lipidic Furan, Pyrrole, and Thiophene Compounds for Treatment of Cancer, Neurological Disorders, and Fibrotic Disorders
  申请人：Avoscience, LLC

  公开号：US20140309274A1

  公开（公告）日：2014-10-16

  Compounds, methods, and compositions are provided for the treatment of cancer, neurological disorders, and fibrotic disorders. Specifically, the invention includes administering an effective amount of a compound of Formula I, II, or III, or a pharmaceutically acceptable composition, salt, isotopic analog, prodrug, or combination thereof, to a subject suffering from a cancer, neurological disorder, or fibrotic disorder.

  本发明提供了用于治疗癌症、神经系统疾病和纤维化疾病的化合物、方法和组合物。具体而言，该发明包括向患有癌症、神经系统疾病或纤维化疾病的受试者施用公式I、II或III的化合物、药学上可接受的组合物、盐、同位素类似物、前药或其组合的有效量。
• LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND FIBROTIC DISORDERS
  申请人：Avoscience, LLC

  公开号：US20160263080A1

  公开（公告）日：2016-09-15

  Compounds, methods, and compositions are provided for the treatment of cancer, neurological disorders, and fibrotic disorders. Specifically, the invention includes administering an effective amount of a compound of Formula I, II, or III, or a pharmaceutically acceptable composition, salt, isotopic analog, prodrug, or combination thereof, to a subject suffering from a cancer, neurological disorder, or fibrotic disorder.

  本发明提供了用于治疗癌症、神经系统疾病和纤维化疾病的化合物、方法和组合物。具体而言，本发明包括向患有癌症、神经系统疾病或纤维化疾病的受试者施用公式I、II或III的化合物或其药学上可接受的组合物、盐、同位素类似物、前药或其组合物的有效量。